Culture

Female language style promotes visibility and influence online

A female-typical language style promotes the popularity of talks in the digital context and turns out to be an underappreciated but highly effective tool for social influence. This was shown by UZH psychologists in an international study in which they analyzed 1,100 TED Talks.

A large part of social interaction nowadays takes place digitally. And the digital age has brought new opportunities to interact and communicate with increasingly large audiences. The huge power for social influence of digital media may come with the risk of intensifying common societal biases, such as gender stereotypes. One behavioral manifestation that plays a major role in such social evaluations is language use. In past research that focused on offline contexts, male characteristics were associated with more influence, while female characteristics tended to be associated with less competence.

Men and women show different language styles

To investigate how gender-linked language styles influence the impact of online contributions and whether they are subject to the same rules as in offline environments, an international research group led by the University of Zurich made use of the TED science platform. The topics of the TED Talks range from technology, entertainment and design (TED) to global issues, business, science and culture, with an average two million views for each talk.

The researchers collected the transcripts of nearly 1,100 TED Talks (348 of which were given by women) in order to identify typical male and female language styles. For this purpose, an index was used that placed each speaker between the extremes of very masculine to very feminine speech, which were empirically defined on the basis of large samples. According to previous research men commonly use more abstract and analytical language while female-typical language has been described as more narrative, personal, social and emotional; women tend to refer more to themselves and to other people more than men.

Female-typical language is linked to higher impact

The researchers correlated the identified speech styles with the number of views as well as the positive and negative ratings the talks received. By doing so, they wanted to find out which language style had a stronger effect in TED Talks: A more instrumental and complex male-typical language style or a simpler and more personal female-typical language style.

"Due to the well documented male advantage in social influence, we expected a general advantage of male-typical language style in terms of talk impact," says first author and UZH psychologist Tabea Meier. "We assumed that this might be the case for women in particular, namely that a male language style might help them overcome the ascribed lower status typically associated with their gender." Instead, the researchers found the opposite - that female-typical language was connected with higher impact.

TED Talks that showed a female-typical language were associated with more talk views irrespective of the speaker's gender. "Female-typical language thus conferred an advantage for male and female speakers alike in our sample," says Meier. "For the most popular TED talks this meant over 700,000 extra views online."

"Beautiful" and "courageous" versus "fascinating" and "informative"

The language style not only predicted the quantitative impact manifested in talk views but also the qualitative impact in types of positive and negative ratings received. More female-typical language style attracted positive ratings like "beautiful", "courageous" and "funny" while male-typical language evoked positive ratings like "ingenious", "fascinating", "informative" and "persuasive".

"These different qualities are in line with common gender stereotypes of women being warmer and emotionally expressive, and men more factual," says author and research group leader Andrea Horn. However, in the digital sphere, unlike offline, such qualities did not interfere with popularity. This was also reflected in the negative ratings of the TED Talks. More female-typical language style also led to fewer "unconvincing" ratings. The authors conclude that a female-typical language style may thus be a powerful tool to promote impact and visibility irrespective of whether the speaker is male or female.

Credit: 
University of Zurich

A pair of lonely planet-like objects born like stars

image: Artist's composition of the two brown dwarfs, in the foreground Oph 98B in purple, in the background Oph 98A in red. Oph 98A is the more massive and therefore more luminous and hotter of the two. The two objects are surrounded by the molecular cloud in which they were formed.

Image: 
© University of Bern, Illustration: Thibaut Roger

Star-forming processes sometimes create mysterious astronomical objects called brown dwarfs, which are smaller and colder than stars, and can have masses and temperatures down to those of exoplanets in the most extreme cases. Just like stars, brown dwarfs often wander alone through space, but can also be seen in binary systems, where two brown dwarfs orbit one another and travel together in the galaxy.

Researchers led by Clémence Fontanive from the Center for Space and Habitability (CSH) and the NCCR PlanetS discovered a curious starless binary system of brown dwarfs. The system CFHTWIR-Oph 98 (or Oph 98 for short) consists of the two very low-mass objects Oph 98 A and Oph 98 B. It is located 450 light years away from Earth in the stellar association Ophiuchus. The researchers were surprised by the fact that Oph 98 A and B are orbiting each other from a strikingly large distance, about 5 times the distance between Pluto and the Sun, which corresponds to 200 times the distance between the Earth and the Sun. The study has just been published in The Astrophysical Journal Letters.

Extremely low masses and a very large separation

The pair is a rare example of two objects similar in many aspects to extra-solar giant planets, orbiting around each other with no parent star. The more massive component, Oph 98 A, is a young brown dwarf with a mass of 15 times that of Jupiter, which is almost exactly on the boundary separating brown dwarfs from planets. Its companion, Oph 98 B, is only 8 times heavier than Jupiter.

Components of binary systems are tied by an invisible link called gravitational binding energy, and this bond gets stronger when objects are more massive or closer to one another. With extremely low masses and a very large separation, Oph 98 has the weakest binding energy of any binary system known to date.

Discovery thanks to data from Hubble

Clémence Fontanive and her colleagues discovered the companion to Oph 98 A using images from the Hubble Space Telescope. Fontanive says: "Low-mass brown dwarfs are very cold and emit very little light, only through infrared thermal radiation. This heat glow is extremely faint and red, and brown dwarfs are hence only visible in infrared light." Furthermore, the stellar association in which the binary is located, Ophiuchus, is embedded in a dense, dusty cloud which scatters visible light. "Infrared observations are the only way to see through this dust", explains the lead researcher. "Detecting a system like Oph 98 also requires a camera with a very high resolution, as the angle separating Oph 98 A and B is a thousand times smaller than the size of the moon in the sky," she adds. The Hubble Space Telescope is among the few telescopes capable of observing objects as faint as these brown dwarfs, and able to resolve such tight angles.

Because brown dwarfs are cold enough, water vapor forms in their atmospheres, creating prominent features in the infrared that are commonly used to identify brown dwarfs. However, these water signatures cannot be easily detected from the surface of the Earth. Located above the atmosphere in the vacuum of space, Hubble allows to probe the existence of water vapor in astronomical objects. Fontanive explains: "Both objects looked very red and showed clear signs of water molecules. This immediately confirmed that the faint source we saw next to Oph 98 A was very likely to also be a cold brown dwarf, rather than a random star that happened to be aligned with the brown dwarf in the sky."

The team also found images in which the binary was visible, collected 14 years ago with the Canada-France-Hawaii Telescope (CFHT) in Hawaii. "We observed the system again this summer from another Hawaiian observatory, the United Kingdom Infra-Red Telescope. Using these data, we were able to confirm that Oph 98 A and B are moving together across the sky over time, relative to other stars located behind them, which is evidence that they are bound to each other in a binary pair", explains Fontanive.

An atypical result of star formation

The Oph 98 binary system formed only 3 million years ago in the nearby Ophiuchus stellar nursery, making it a newborn on astronomical timescales. The age of the system is much shorter than the typical time needed to build planets. Brown dwarfs like Oph 98 A are formed by the same mechanisms as stars. Despite Oph 98 B being the right size for a planet, the host Oph 98 A is too small to have a sufficiently large reservoir of material to build a planet that big. "This tells us that Oph 98 B, like its host, must have formed through the same mechanisms that produce stars and shows that the processes that create binary stars operate on scale-down versions all the way down to these planetary masses", comments Clémence Fontanive.

With the discovery of two planet-like worlds - already uncommon products of star formation - bound to each other in such an extreme configuration, "we are really witnessing an incredibly rare output of stellar formation processes", as Fontanive describes.

Bernese space exploration: With the world's elite since the first moon landing

When the second man, "Buzz" Aldrin, stepped out of the lunar module on July 21, 1969, the first task he did was to set up the Bernese Solar Wind Composition experiment (SWC) also known as the "solar wind sail" by planting it in the ground of the moon, even before the American flag. This experiment, which was planned and the results analysed by Prof. Dr. Johannes Geiss and his team from the Physics Institute of the University of Bern, was the first great highlight in the history of Bernese space exploration.

Ever since Bernese space exploration has been among the world's elite. The numbers are impressive: 25 times were instruments flown into the upper atmosphere and ionosphere using rockets (1967-1993), 9 times into the stratosphere with balloon flights (1991-2008), over 30 instruments were flown on space probes, and with CHEOPS the University of Bern shares responsibility with ESA for a whole mission.

Credit: 
University of Bern

Turning sweat against itself with a metal-free antiperspirant

Body odor is an unpleasant smell, produced when bacteria living on the skin break down the proteins in sweat. To avoid stinking, some people apply antiperspirants that clog sweat ducts with foreign materials, such as metals, to slow perspiration. As a step toward a more natural solution, researchers reporting in ACS Applied Materials & Interfaces have turned sweat against itself using an evaporation-based approach in which the salts in sweat create a gel-like plug.

Most commercial antiperspirants use metallic salts, such as aluminum chlorohydrate, to clog sweat ducts. Years ago, it was suggested that using these products could increase the risk of developing breast cancer, but according to the National Cancer Institute, no scientific evidence exists that confirm those claims. Nevertheless, consumer and regulatory demand has increased for natural, non-metallic alternatives. Because propylene glycol strongly attracts water and is "generally recognized as safe" by the U.S. Food & Drug Administration, Jonathan Boreyko and colleagues wanted to see if it would draw the water out of sweat, leaving behind a natural salt blockade that would stop the flow.

To simulate a sweat duct in the laboratory, the researchers slowly pushed an artificial sweat solution through a thin glass tube. Then, they placed a polymer cube covered in propylene glycol near the opening. The sweat solution initially bubbled, then formed a gel-like plug that obstructed the tube within two minutes. However, when the cube did not contain propylene glycol or the cube was absent, sweat continually exited the outlet and ran along the outside surface of the tube. The team used glass tubes that were 3.3 times wider than real sweat ducts in human skin, but their models suggest that applying a propylene glycol film directly on skin would also result in dehydrated salts and plug formation. The next step in this research would be to conduct human trials to compare the comfort and effectiveness of a film made of propylene glycol, or other water-attracting materials, against traditional metal-based antiperspirants, the researchers say.

Credit: 
American Chemical Society

Clemson researcher identifies gene teams working in subregions of brain

image: Clemson University graduate student Yuqing "Iris" Hang said researchers must know how genes interact in a normal brain before they can look at whether they act differently in brain tumors or in people with intellectual disabilities.

Image: 
Photo courtesy of Clemson University College of Science and Yuqing

CLEMSON, South Carolina - You must first understand how something works normally before you can figure out why it's broken.

That's the idea behind brain research by Yuqing "Iris" Hang, a Clemson University graduate student pursuing a doctorate in biochemistry in the College of Science's Department of Genetics and Biochemistry.

Hang is studying how genes interact in a normal brain.

"When studying a disease trait, we always need to compare that trait to the normal condition," she said.

An article published recently in Scientific Reports titled "Exploration into biomarker potential of region-specific brain gene co-expression networks" describes Hang's research.

Hang used RNA-seq gene expression profiles from the National Institutes of Health Genotype-Tissue Expression (GTEx) project and software called the Knowledge Independent Network Construction (KINC) to sort thousands of genes into gene groups that team up in specific parts of the normal human brain. Clemson professor Alex Feltus and former graduate student Stephen Ficklin, who is now an assistant professor at Washington State University, developed KINC. Hang is a student in Feltus' Systems Genetics Lab.

Hang then constructed six mini gene co-expression networks for a normally functioning brain and conducted additional statistical tests to reveal correlations between genes and cellular pathways in the brain. In a gene co-expression network, two genes with a high likelihood of interacting with each other will be connected by a line called an edge.

During her analysis, Hang found teams of genes working in all parts of the brain -- but only in the brain -- and she also found teams of genes working in subregions of the brain.

"We have brain biomarkers -- genes that are co-expressed pair-wise in different brain tissues -- that are evidence that they are probably doing something normal in those tissues they're not doing in other tissues. They have some collective function," Feltus said. Researchers can now test each of those gene teams to see if gene pairs are changing in brain tumors or in people with intellectual disabilities.

"Now we know what genes are interacting normally in the brain, and then we can test and see if those interactions don't exist in disease," he said.

One notable finding is that genes in the six brain mini gene co-expression networks showed higher mutation rates in tumors than in matched sets of random genes.

"This means those genes could play an important role in brain development. The mutation of those genes would increase the chances of getting a brain tumor or brain-related disease," Hang said.

Feltus called Hang's research a step toward the goal of finding gene teams that are controlling phenotypes.

"One hundred years from now, I don't think there will be any cancer, and I think we'll understand how intellectual disabilities are occurring," he said.

Credit: 
Clemson University

BAME babies at highest risk of Vitamin D deficiency

A third of all babies and half of Black, Asian and Minority Ethnic (BAME) babies are vitamin D deficient, a large study of 3000 newborn's in the West Midlands has shown, highlighting potential shortfalls in the current UK antenatal supplementation programme.

Vitamin D, sometimes referred to as the 'sunshine vitamin' helps the body absorb calcium and phosphate from our diet making it vital for healthy bones, teeth and muscles. As well as causing bone softness and weakness, vitamin D deficiency in newborn infants can lead to serious life-threatening complications such as seizures, serious heart conditions and, rarely, death in the first months of life. With very few dietary sources of vitamin D, supplementation programmes are in place to ensure adequate vitamin D consumption in high risk groups which include pregnant women and children.

This latest study, led by experts at the University of Birmingham and Birmingham Women's and Children's NHS Foundation Trust, analysed vitamin D levels on 3000 dry blood samples, collected via a heel prick in the first week of life as part of the national Newborn Blood Spot screening programme. Samples were strategically collected at the end of summer and winter to capture the peak and trough in vitamin D levels. Vitamin D levels were analysed alongside ethnicity, gestational age, maternal age and also deprivation indices. Proportion of babies with deficient, insufficient and sufficient levels of vitamin D based on season of birth and ethnicity were evaluated.

The majority of newborn's tested were white British (59.1%) and born at term. Vitamin D deficiency was present in 35% of the cohort. The results also demonstrate significant seasonal differences with 52.6% of winter-born babies being vitamin D deficient compared with 18.4% of summer-born babies. Nearly a quarter of babies tested (24%) were from areas with high levels of social deprivation.

Perhaps most significant is the prevalence of vitamin D deficiency between ethnic groups. Compared to white British babies, concentrations of the vitamin were much lower in babies of Black, Asian and mixed races as well as non-British white babies. Overall, across both seasons nearly half of the babies from Asian and black ethnic backgrounds were found to be deficient in vitamin D (47.7% and 47.4%, respectively) compared with 30.3% of white British babies. Across the entire multi-ethnic cohort, nearly 70% of the babies had a low vitamin D status, meaning that two thirds of the babies tested were either deficient or had insufficient levels.

Lead author Dr Suma Uday from the University of Birmingham and Birmingham Women's and Children's hospital said: "Vitamin D deficiency is common in all babies born in the UK, especially in winter months. The high proportion of dark-skinned infants with low vitamin D status, demonstrates potential failings of the UK's national antenatal supplementation programme in protecting these ethnic groups, who are well recognised to be at a high risk of vitamin D deficiency. We need to work on improving the disconnect between provision and uptake of vitamins in high risk-groups like expectant mothers from BAME backgrounds."

Senior author Professor Wolfgang Högler from the University of Birmingham's Institute of Metabolism and Systems Research said: "Our findings suggest that vitamin D supplementation programmes could be much improved if they were delivered and monitored like immunisation programmes. Much easier and more effective would be food fortification with vitamin D - an approach that we have seen to be successful in other high latitude countries, such as Finland"

Credit: 
University of Birmingham

Whole genomes map pathways of chimpanzee and bonobo divergence

Chimpanzees and bonobos are sister species that diverged around 1.8 million years ago as the Congo River formed a geographic boundary and they evolved in separate environments. Now, a whole-genome comparison of bonobos and chimpanzees reveals the gene pathways associated with the striking differences between the two species' diets, sociality and sexual behaviors.

The journal Genes, Brain and Behavior published the comparative analysis, conducted by anthropologists at Emory University.

"Our paper is the first whole-genome positive selection scan between chimpanzees and bonobos," says John Lindo, Emory assistant professor of anthropology and senior author of the study. "We contrasted the genomes of both species to understand how natural selection has shaped differences between the two closely related primates."

Lindo is a geneticist specialized in ancient DNA and natural selection. "Chimpanzees and bonobos are fascinating because they are very, very closely linked genetically but they have huge behavioral differences," he says.

The two species also share around 99 percent of human DNA, making them our closest living relatives in the animal kingdom. "Understanding the physiological mechanisms underlying the differences in chimpanzee and bonobo behaviors -- particularly the much stronger propensity of bonobos toward conflict resolution instead of fighting -- may also give us information about the genes underlying our own behaviors," Lindo says.

Sarah Kovalaskas, an Emory graduate student of anthropology, is first author of the paper. Before joining Emory she spent nine months in the field, studying the social development of juvenile bonobos in the Democratic Republic of Congo (DRC). Wild bonobos, an endangered species, are only found in forests south of the Congo River in the DRC.

"Bonobos are well-known for being playful, even as adults," Kovalaskas says. "It was fun to observe the juveniles twirling around in the trees, chasing one another and trying to pull each other down. When the mothers tried to wean them, they would sometimes throw tantrums and scream and run around. You can't help but recognize the similarity in behaviors to humans."

Populations of chimpanzees, also an endangered species, are found in a forested belt north of the Congo River and scattered in a few other areas of west and central Africa.

Bonobos and chimpanzees closely resemble one another physically and they were not recognized as separate species until the 1930s. Their behavioral differences are much more distinct. While bonobos organize into female-led societies, chimpanzees are patriarchal. When bonobos encounter other bonobo groups they generally interact peacefully. Bonobos are also known for using sexual behaviors to defuse tension -- including same-sex behaviors among females. Chimpanzees, however, tend to act more aggressively when encountering other chimpanzee groups and may even have violent exchanges that include fatalities.

A leading hypothesis suggests that different feeding ecologies were key to the behavioral divergence between the two species. This theory posits that the abundant ground vegetation in the bonobo territory provided easy access to year-round food without competition from other individuals. Larger groups could feed together instead of foraging in isolation, allowing females to develop strong bonds to counter male domination, and to mate with less aggressive males, leading a kind of "self-domestication."

The whole genome comparison showed selection in bonobos for genes related to the production of pancreatic amylase -- an enzyme that breaks down starch. Previous research has shown that human populations that began consuming more grains with the rise of agriculture show an increase in copies of a closely related gene that codes for amylase.

"Our results add to the evidence that diet and the available resources had a definite impact on bonobo evolution," Kovalaskas says. "We can see it in the genome."

Compared to chimpanzees, bonobos also showed differences in genetic pathways well-known to be related to social behaviors of animals -- as well as humans. Bonobos had strong selection for genes in the oxytocin receptor pathway, which plays a role in promoting social bonds; serotonin, involved in modulating aggression; and gonadotropin, known to affect sexual behavior.

"The strong female bonds among bonobos, in part, may be mediated by their same-sex sexual behaviors," says co-author James Rilling, professor and chair of Emory's Department of Anthropology. "Our data suggest that something interesting is going on in the bonobo pathways for oxytocin, serotonin and gonadotropin and that future research into the physiological mechanisms underlying behavioral differences between bonobos and chimpanzees may want to target those specific systems."

Credit: 
Emory Health Sciences

Cancer: Tumor driver promoting EMT, metastasis and resistance to therapy

Cancer metastasis, which is the dissemination of tumor cells into distant organs,
is the leading cause of mortality in cancer patients. To undergo metastasis, cells must
leave the primary tumor, circulate into the blood, colonize distant organs, and form distant metastasis. It has been proposed that epithelial to mesenchymal transition (EMT), a process in which epithelial cells detach from their neighboring cells, and acquire mesenchymal migrating properties, is important to initiate the metastatic cascade allowing the cancer cells to leave the primary tumor. However, the role of genetic mutations in promoting EMT is unknown.

FAT1 is among the most frequently mutated driver genes in a broad range of human cancers. The loss of function mutations in this gene suggest that FAT1 acts as tumour suppressor, preventing cancer development. However, and despite the high frequency of FAT1 mutations, its role in cancer is poorly understood.

In a study published in Nature, researchers led by Prof. Cedric Blanpain, MD/PhD, WELBIO investigator, Director of the Laboratory of Stem Cells and Cancer and Professor at the Université libre de Bruxelles, Belgium, demonstrated, for the first time, that loss of FAT1, promote EMT, invasive features and metastasis in skin squamous cell carcinoma -the second most frequent cancer in humans-, lung cancer -the deadliest cancer - and head and neck tumors.

Ievgenia Pastushenko and colleagues used state of the art genetic models of skin and lung cancers, as well as human skin, lung and head and neck tumors to assess
the role of FAT1 in cancer.

The authors discovered that loss of function of FAT1, promotes hybrid EMT phenotype, characterized by the co-expression of epithelial and mesenchymal genes in tumor cells. The authors demonstrated that this hybrid EMT
state occurring following FAT1 loss of function, promotes metastasis and was associated with poor clinical outcome in patients with lung cancers. "It was particularly
exciting to identify that mutations in a single gene, FAT1, promote hybrid EMT state, leading to metastasis and associated with poor prognosis in cancer patients" comments Ievgenia Pastushenko, the first author of this study.

Using different molecular approaches, the authors decipher the mechanisms by which FAT1 mutations promote hybrid EMT state. "The identification of the mechanisms
that promote this highly metastatic tumor state, allowed us to identify drug resistance and vulnerabilities in FAT1 mutated cancers. We found that Fat1 mutated cancers are
highly resistant to several drugs including EGFR inhibitor that are frequently used to treat patients with lung cancers. Most interestingly, we identify that FAT1 mutated cancers are particularly sensitive to other drugs including Src inhibitor that are currently used to treat patients with blood cancer. These findings will have very important and
immediate implications for personalized therapy in patients FAT1 mutated cancers", comments Pr Cedric Blanpain, the
senior author of this study.

Credit: 
Université libre de Bruxelles

Connections determine everything

image: Stroke Popular Figure

Image: 
M.Nzarova et al.

A team of scientists, with the first author from the HSE University, were investigating which factors are the most important for the upper limb motor recovery after a stroke. The study is published in Stroke.

, the world's leading journal for cerebrovascular pathology.

A stroke occurs when there is a blockage or rupture of a blood vessel feeding the brain. About 400,000 stroke cases are registered in Russia annually. Stroke is a disease, which occurs mostly in older ages but not only, for instance in Russia every 7th stroke happens in young people. Today there are more than 1.5 million people living in Russia who are in need of motor, speech, or cognitive rehabilitation due to stroke. The impairment in the upper limb is the most common and one of the most challenging for rehabilitation.

The extent to which the brain is damaged and movements are impaired after a stroke varies greatly among patients. How effectively a patient will regain his/her functions after a stroke depends both on the severity of the damage and the adequacy of the rehabilitation interventions. Assessment can be conducted using functional and structural approaches of brain imaging.

The published article is dedicated to a study of the relationship between the degree of movement recovery in the upper limb and the structural and functional state of the motor system, assessed using methods of transcranial magnetic stimulation (TMS) and magnetic resonance imaging (MRI). The study included 35 patients of young and middle age (in average 47 years old), who had a stroke more than six months prior to the study. The patients were divided into three groups depending on the level to which they regained movement in their upper limb: good, moderate, and bad.

The study showed that the structural integrity of the corticospinal tract assessed using structural MRI is the best predictor for the upper limb motor recovery. At the same time, the assessment of the state of the unaffected cerebral hemisphere and the integrity of the connections between the hemispheres did not have an additional value for classification when data on the integrity of the corticospinal tract were available.

The corticospinal tract is a pathway that connects the cerebral cortex with the spinal cord, allowing voluntary limb movement.

In addition, the study showed that the methods of MRI and TMS are equally effective for assessing the condition of the corticospinal tract in patients in chronic phase after stroke and can be used interchangeably when it is necessary to select a group of patients with low levels of recovery.

'However, it is important to consider that when assessing the motor system using TMS, it is necessary to study the evoked motor responses in several muscles of the upper limb. This makes it possible to reduce the number of false negative results--cases in which muscle responses to stimulation were not found, although the corticospinal tract was partially preserved,' says Maria Nazarova, research fellow at the Institute for Cognitive Neurosciences of HSE University.

The findings of the study can be used both to better understand the processes of recovery after a stroke and to plan individual motor rehabilitation in stroke survivors.

Credit: 
National Research University Higher School of Economics

Some neurons target tiny cerebral blood vessel dilation

image: Section of a brain showing neurons that have nNOS-expressing neurons labeled in green, DREADD-expressing neurons in magenta. Neurons that express both show up as white.

Image: 
Jordan Norwood, Penn State

Neurons control blood flow in tiny vessels in the brain, but researchers know little about this relationship. Now a team of Penn State engineers has found a connection between nitric oxide expressing neurons and changes in arterial diameters in mice, which may shed light on brain function and aging.

"The brain has many types of neurons," said Patrick J. Drew, Huck Distinguished Associate Professor of Engineering Science and Mechanics, Neurosurgery and Biomedical Engineering. "People have observed that blood flow and neural activity go together, and we wanted to measure the blood flow and activity in specific subtypes of neurons."

The researchers looked for a way to turn neurons off and on so that they could determine which neurons dilated the blood vessels.

"We knew that when animals run, all the neurons become more active and this causes the blood vessels to react," said Drew. "There are excitatory and inhibitory neurons and there is some evidence that if you stimulate inhibitory neurons you get vasodilation, but there are lots of inhibitory neuron types. We wanted to find out which ones were responsible."

The researchers used two-photon microscopy to look at the surface and deep arteries in the somatosensory cortex of mice while the mice were awake. They were able to make multiple observations of the same arteries in the same animals over a series of different neural perturbations, so they could compare results in individuals rather than across individuals. They reported their results in eLife.

"Thirty years ago people realized that nitric oxide is a vasodilator," said Drew. "Other researchers have seen an enzyme of nitric oxide stimulate a subset of neurons giving us a hint that this could help locate the responsible neurons."

Drew and his team showed that with an increase or decrease of the nitric oxide enzyme there was a change in dilation without there being a change in electrical activity. According to Drew, the brain is oversupplied with oxygen, so an increase in dilation when running or for other reasons is not necessarily to increase oxygen supply.

"The changes do not seem to be linked with need," said Drew. "It is a mystery why it happens."

Because the researchers could track changes in the same blood vessel over time and with different stimuli, they could compare these changes to the baseline in the individual animals. They could also inhibit certain groups of neurons for various lengths of time.

"Our results suggest a model where approximately half of the dynamic range in the basal and evoked blood arterial diameter is controlled by a small group of neurons and the rest is controlled by other neurons and astrocytes," the researchers report. "Any damage to or dysfunction of nNOS neurons (producing nitric oxide enzymes) could result in decreased basal blood flow, regardless of the metabolic need."

The researchers also noted that changes in the diameter of blood vessels affects the amplitude of fmri signals. Because fmri is used to image blood vessels in animals and humans, this can produce signals not related to neural activity.

"This tells us that fmri signals may not represent overall activity," said Drew. "It suggests that if these neurons die, it might cause the development of dementia."

The researchers would like to know what happens if these neurons are shut down for a long time. They would also like to know what happens if these same neurons are stimulated for a long time. Another goal is to understand what drives these neurons, what modulatory input do they receive and in what other parts of the brain do they function?

Credit: 
Penn State

The bull's eye: New modified stem cells can deliver drugs specifically to tumor cells

video: Researchers from Tokyo University of Science have successfully modified Mesenchymal stem cells (MSCs) to deliver large quantities of anti-cancer drugs in a targeted manner to developing cancer cells.

Image: 
Tokyo University of Science

As humans evolve, cancer also evolves in parallel, making the race for finding efficient treatment methods for cancer patients challenging and constant. In addition to designing drugs for treatment, the delivery of these drugs to targeted organs is also a major challenge faced by the cancer research community.

Many research groups have tried to develop techniques to efficiently deliver anti-cancer drugs to tumors. An interesting way utilizes a distinct group of cells in our body, the mesenchymal stem cells (MSCs), which have a special ability to find and move towards tumors. This means that theoretically, we can load these "tumor-homing" MSCs with anti-cancer drugs and use them to hinder cancer progression. However, pilot studies show that the anti-cancer drug loading capacity of MSCs is limited, and they tend to lose their ability to target and reach tumor cells upon drug loading.

In a recent study published in Journal of Controlled Release, researchers from Japan, led by Dr. Kosuke Kusamori and Professor Makiya Nishikawa from Tokyo University of Science, sought to find out how to modify MSCs to bypass these problems. Dr. Kusamori, Assistant Professor in the University's Department of Pharmacy says, "We wondered if the answer to our dilemma of modifying mesenchymal stem cells with an anticancer drug was to exploit the property of mesenchymal stem cells to accumulate in tumor tissues."

Using the well-known "avidin-biotin complex" (ABC) method, the researchers used liposomes--cellular lipid bags popularly used as drug delivery systems--to carry the anti-cancer drug doxorubicin (DOX) to the surface of specific mouse MSCs. They named these lipid bags carrying DOX "DOX-Lips."

The researchers found that the MSCs loaded with DOX-Lips could carry and selectively target mouse colon cancer cells growing in artificial cultures in the lab. These modified MSCs could not only carry a significant amount of the drug, but also efficiently deliver it inside the target cancer cells. To test if this feature is replicated in a living system, they used a mouse model with skin and lung cancer. They found that in both cases, DOX-Lips were able to efficiently reach cancer cells and release the drug into the cytoplasm of the cancer cells. The researchers concluded that the modified MSCs could completely suppress tumor growth in mouse models.

There are several advantages to this new method. First, the process is relatively faster than previously known methods. As Yukiya Takayama, a doctoral student in Professor Nishikawa's lab and a co-author of the study observes, "The relatively short duration of the ABC method made it possible to quickly modify the cell surface with DOX-Lips and avoid cell damage." Second, this method did not affect the process of cell attachment to cancer cells, thereby ensuring maximum efficiency in drug delivery. Third, contrary to previous observations that lipid bags of only a certain size can be used to deliver drugs, this new study suggests that the size of the lipid bags very likely does not affect drug delivery; this finding can be exploited to deliver many different doses of drugs as well.

The combination of the ABC method and the use of Lips thus seems to be the answer to the researchers' dilemma. Professor Nishikawa is excited about these results. "We have succeeded in developing a new targeted cancer therapy," he observes. "Mesenchymal stem cells can migrate to brain tumors and minute cancer lesions that are otherwise inaccessible to conventional drug delivery systems. Our method may thus be effective against intractable cancers," Nishikawa says.

This study is thus a promising advancement in the field of cancer research; the new method identified by the researchers may prove to be the answer on how to send the treating drug to cancer's doorstep.

Credit: 
Tokyo University of Science

New screening platform leads to discovery of next-generation prodrugs for type 1 diabetes

With nearly 2 million Americans battling type 1 diabetes, it is no surprise that clinical therapies for the disease are constantly evolving and improving. In type 1 diabetes mellitus, the body's immune system attacks and destroys insulin-producing β-cells. As a result, people living with type 1 diabetes lose insulin secretion and encounter difficulty regulating glucose levels -- especially after meals. Drugs developed to proliferate β-cells often are inefficient and have off-target effects that can dysregulate other cell types and pancreatic hormone production. To address these issues, researchers at Brigham and Women's Hospital and the Broad Institute teamed up to design next-generation β-cell-targeting proliferators: zinc-binding prodrugs (ZnPD). To achieve this, the researchers engineered a new screening platform, the Disque Platform, to better represent β-cells in the lab. Utilizing the Disque Platform, researchers identified a ZnPD drug which exhibited a 2.4-fold increase in β-cell numbers in culture, out-performing its native drug, harmine, and avoiding off-target effects. Results are published in Science Advances.

"We exploited a unique feature of β-cells, which contain at least a million-fold more intracellular zinc ions than other cell types for insulin processing," said Amit Choudhary, PhD, a member of the Brigham's divisions of Renal Medicine and Engineering in Medicine and an associate member of the Broad Institute. "The ZnPD leverages principles in chemical biology to switch on the proliferators specifically in β-cells, preventing unwanted proliferation in other cell types and systemic cytotoxicity while promoting sustained β-cell proliferation."

With no durable and effective treatments for β-cell loss, researchers capitalized on this high zinc concentration in β-cells to guide their drug development. "Our novel drug type attaches an inactive β-cell proliferator to both a molecule with high affinity for zinc, known as a chelator, and a linker molecule, whose job is to stabilize the overall chemical structure," said Kisuk Yang, PhD, a postdoctoral fellow in the Karp Lab. Upon zinc binding to the chelator, the β-cell proliferator is released and begins promoting the proliferation of β-cells. However, another challenge faced by the researchers when testing the safety and efficacy of ZnPDs was the lack of accurate screening method.

Conventional screening platforms cannot reproduce the exceptionally high levels of zinc ions found in β-cells, which was essential in the design of ZnPDs. Alternatively, 3D culture systems preserve morphological and biological complexity, but are expensive and complex, and thus impractical for use in drug screening.

"To overcome these challenges, we engineered the Disque Platform: a new screening platform which combines 2D simplicity with 3D architecture. In this platform, cells are shaped into thin discs, which can accommodate both conventional 2D well plates and 3D bioreactors," said Peter Jones, a previous graduate student at Karp Lab and co-first author.

In developing the ZnPD mechanism of action, researchers looked to harmine, a type 1 diabetes drug recently found to induce β-cell proliferation but with toxic effects. Using the Disque Platform, the researchers screened multiple ZnPDs and identified a novel hit that exhibited a 2.4-fold increase in the generation of β-cells compared to harmine. Importantly, this ZnPD did not exhibit off-target effects and toxicities. The ZnPD represents a novel, chemical-biology-based drug carrier for targeted cell delivery.

"The Disque Platform can support rapid and cost-effective production of disc-shaped pseudo-islets in vitro that can be used to discover more effective drugs, and to advance a long-term cell transplantation strategy for diabetic therapy," said Jeff Karp, PhD, head of The Karp Lab and member of the Brigham's Department of Anesthesiology and Perioperative Pain Medicine. Karp is also an associate member of the Broad Institute. "In the future, the Disque Platform may be adapted to culturing other islet types or small-scale organoids for reliable drug screening applications. The implications for both this novel ZnPD and the Disque Platform are widespread, spanning beyond diabetes research."

Credit: 
Brigham and Women's Hospital

New guideline supports behavioral, psychological treatments for insomnia

DARIEN, IL - The American Academy of Sleep Medicine has published a new clinical practice guideline establishing recommendations for the use of behavioral and psychological treatments for chronic insomnia disorder in adults.

The guideline includes one strong recommendation -- which is one that clinicians should follow under most circumstances -- for the use of cognitive behavioral therapy for insomnia. CBT-I combines one or more cognitive therapy strategies with education about sleep regulation plus behavioral strategies such as stimulus control instructions and sleep restriction therapy. Treatment typically involves four to eight sessions.

"This is the first systematic review to use the GRADE system to evaluate behavioral insomnia therapies," said lead author Jack Edinger, who has a doctorate in clinical psychology and is a professor in the section of sleep medicine at National Jewish Health in Denver. "The multicomponent treatment, cognitive behavioral therapy for insomnia, is the most supported therapy."

Published online as an accepted paper in the Journal of Clinical Sleep Medicine, the guideline updates the AASM's 2006 practice parameters. It was developed by an expert task force and approved by the AASM board of directors. The process included a systematic literature review, meta-analyses, and assessment of the evidence using the GRADE methodology. A draft of the guideline was made available for public comment.

"There have been significant advancements in behavioral and psychological treatments for chronic insomnia, which affects millions of American adults," said AASM President Dr. Kannan Ramar. "The AASM guideline will help optimize patient-centered care by providing actionable recommendations for clinicians and patients."

The guideline includes several conditional recommendations -- which require the clinician to use clinical knowledge and experience while considering the patient's values and preferences -- suggesting that clinicians use multi-component brief therapies and three single-component therapies: stimulus control, sleep restriction therapy, and relaxation therapy. The guideline also suggests that sleep hygiene should not be used as a single-component treatment for chronic insomnia disorder in adults.

"Although sleep hygiene practices are often suggested and well-understood by patients, sleep hygiene recommendation do not constitute an effective stand-alone therapy," said Edinger.

Insomnia involves difficulty falling asleep or staying asleep, or regularly waking up earlier than desired, despite allowing enough time in bed for sleep. Daytime symptoms include fatigue or sleepiness; feeling dissatisfied with sleep; having trouble concentrating; feeling depressed, anxious, or irritable; and having low motivation or energy. Chronic insomnia disorder, which affects about 10 percent of the adult population, is distinguished by a sleep disturbance with associated daytime symptoms occurring at least three times per week for at least three months.

The AASM's previously published clinical practice guideline for the pharmacologic treatment of chronic insomnia also emphasizes that medications for chronic insomnia disorder should be considered mainly in patients who are unable to participate in CBT-I, patients who still have symptoms after this therapy, or those who require a temporary adjunct to CBT-I.

Credit: 
American Academy of Sleep Medicine

An atlas of S. pneumoniae and host gene expression during colonization and disease

image: Carlos Orihuela

Image: 
UAB

BIRMINGHAM, Ala. - The bacteria Streptococcus pneumoniae colonizes the nasopharynx and can cause pneumonia. Then, it can spread from the lungs to the bloodstream and cause organ damage. This opportunistic pathogen commonly infects young children, those who are immunocompromised and the elderly. In 2015, S. pneumoniae infections worldwide killed an estimated 192,000 to 366,000 children under age 5.

To understand how this pathogen adapts to different locations in the body, and also how the host responds to the invading microbe, researchers at the University of Alabama at Birmingham, the University of Maryland School of Medicine and Yale University School of Medicine measured bacterial and host gene expression at five different sites in a mouse model -- the nasopharynx, lungs, blood, heart and kidneys -- using three genetically different strains of S. pneumoniae.

Their resulting in vivo atlas of host-pathogen interactions at disease-relevant anatomical sites is now published in Proceeding of the National Academy of Sciences. The researchers identified shared and organ-specific transcriptomes of S. pneumoniae, and they showed that the bacterial and host gene expression profiles are highly distinct during asymptomatic colonization versus disease-causing infection.

This means the bacterium behaves differently, depending on which site it infects, and that the mouse organs, in turn, also respond differently to the presence of bacteria. Additionally, certain S. pneumoniae genes were found to always be highly expressed by all three strains of bacteria at all anatomical sites, which makes them ideal targets for new vaccines or therapies.

This was the first time that gene expression profiles during colonization and at multiple host infection sites were mapped from both the host and the pathogen perspectives.

"We believe that the atlas of transcriptional responses during host-pathogen interactions presented here," the authors wrote, "will constitute an essential resource for the pneumococcal and microbial pathogenesis research communities and serve as a foundation for identification and validation of key host and pneumococcal therapeutic targets in future studies."

Carlos J. Orihuela, Ph.D., professor in the UAB Department of Microbiology, and Hervé Tettelin, Ph.D., professor in the University of Maryland School of Medicine Department of Microbiology and Immunology, are co-senior authors.

Besides a descriptive analysis of the transcriptomes, researchers confirmed their findings using bacterial mutants, in vivo challenge experiments and host treatments. In challenge experiments, the researchers found that an interferon beta anti-inflammatory treatment prevented the bacteria from invading vital organs and promoted host survival. This finding offers potentially new therapeutic avenues.

Symptoms of pneumococcal infection include fever, cough, shortness of breath, chest pain, stiff neck, confusion, increased sensitivity to light, joint pain, chills, ear pain, sleeplessness and irritability. While advances in antibiotics and the use of pneumococcal conjugate vaccines since 2000 have lowered deaths attributable to S. pneumoniae, the pathogen continues to show an increase in antibiotic resistance, and it also can switch to capsule types that are not covered by the current United States Food and Drug Administration-approved vaccines. Thus, pneumococcal infections continue to be a significant cause of illness and death.

Credit: 
University of Alabama at Birmingham

Maternal diet during lactation shapes functional abilities of milk bacteria

Research has shown that human milk is the optimal nutrition source for neonates and infants. It confers protection against both immediately life-threatening infant diseases such as necrotizing enterocolitis, as well as later onset diseases in adults, like obesity, diabetes and inflammatory bowel disease. Scientific evidence suggests that what a mother eats while she is breastfeeding can modulate the beneficial composition of the mother's milk, but the underlying mechanisms involved have not been elucidated.

In a new study published in Nature Scientific Reports, researchers from Baylor College of Medicine, Texas Children's Hospital and other institutions describe a natural mechanism that can modify the benefits of maternal milk. They report the first evidence that the mother's diet while breastfeeding can shape the profile of human milk oligosaccharides (HMO), a type of complex carbohydrate in the mother's milk. Changing the HMOs, which are food and fodder for healthy microbes, in turn modifies the functional abilities of the milk microbiome. It has been proposed that the establishment of a healthy microbiome in the newborn and infant influences lifelong metabolic health.

"In previous work in both humans and primates, we found that what a pregnant woman eats during pregnancy has the capacity to affect her child's lifelong metabolic health. In the current study we present the first evidence showing that the diet of a breastfeeding mother can directly affect the milk's HMO composition," said senior and corresponding author Dr. Kjersti Aagaard, Henry and Emma Meyer Chair in Obstetrics and Gynecology and professor of molecular and human genetics at Baylor.

"This was particularly exciting, since HMOs are basically inert substances to a mother or her baby. However, they exert their health benefits by acting as food or fodder to microbes -- both bacteria and some viruses. This appears to be a very interesting example where what we eat affects our microbes via an intermediate (the HMOs), which we make but don't directly benefit from. It gives us a fascinating glimpse into what we and others believe is a natural co-evolution process," Aagaard said.

Working with Dr. Morey Haymond, professor of pediatrics-nutrition at Baylor, the team of researchers supplied breastfeeding mothers with all their meals in a controlled setting at the USDA Children's Nutrition Research Center. The mothers consumed a particular diet for 30 to 70 hours. After a two-week washout period, the same woman ate a different diet also provided by the researchers.

The researchers carefully collected milk samples from each subject at these different time points including the diet "switches." In this way, each woman could serve as her own control, something referred to as a "cross-over" trial design. This helped the researchers to control for the possibility of how individual women may vary one to the next in the amount of HMOs made, as well as the possibility of confusing microbes in the milk with environmental contaminants. The team analyzed the HMO and microbiome composition of the milk and gleaned clues as to the effect of the mothers' diet.

"We found that distinct maternal carbohydrate and energy sources in the diets we provided preferentially altered the milk concentrations of HMOs, and this was accompanied by changes in the metabolic capacity of the milk microbiome," said first author Dr. Maxim Seferovic, instructor of obstetrics and gynecology at Baylor working in the Aagaard lab. "It is not that the maternal diet itself is directly affecting the microbes, but that the diet affects the microbes' food, the HMOs, which in turn shape the functional capacity of the community of microbes in the milk that will be consumed by the baby. Interestingly, the changes in HMO occurred quickly, in a matter of 2 to 3 days, after the mothers changed their diet."

The researchers propose that the findings can have implications not only for the baby but also for the mother.

"We propose that our findings can have potential effects on baby's health and development, including the potential for promoting healthy gut integrity at the mucosal surface. HMOs feed certain microbial communities, and it has been suggested that the establishment of those microbial communities is probably important for neonatal development of brain function," said co-author Dr. Melinda Engevik, postdoctoral fellow in pathology and immunology at Baylor. "We speculate that having certain HMOs promotes the growth of certain microbes in the milk, which then pass to the baby and may promote healthy development."

"One other exciting aspect of our study is the suggestion that HMOs seem to preferentially affect the growth potential of microbes that may also impart health risk or benefit for the mother. For instance, by shaping the community of microbes in the milk in ways that may favor the growth of certain beneficial microbes via the simultaneous exclusion of those that cause mastitis during breastfeeding," Aagaard said.

If not treated with antibiotics, mastitis, or the painful inflammation of breast tissue that typically involves an infection, prevents breastfeeding and can become a serious condition.

HMOs also can potentially prompt a healthy microbiome in other ways. For example, by feeding the good microbes, acting as a decoy that attracts and sequesters potentially dangerous microbes and by breaking down HMOs and producing nutrients that may benefit other microbes.

Credit: 
Baylor College of Medicine

New use for an old drug: How does ketamine combat depression?

A group of proteins called 4E-BPs, involved in memory formation, is the key to unlocking the antidepressant effect of ketamine in the brain, according to researchers from three Canadian universities. The discovery could lead to better and safer treatments for certain patients suffering from major depression.

Because more than 30% of patients are resistant to selective serotonin reuptake inhibitors (SSRI), the most commonly-prescribed antidepressants, finding an effective treatment for major depressive disorder is challenging.

Initially, ketamine was approved for anesthesia and pain relief. Since its discovery, researchers have been studying new uses for this drug, and ketamine was approved last year for patients with major depression who are treatment-resistant. Unlike standard antidepressants, which can take several weeks to have an effect, ketamine works within hours. Until now, little was known about the molecular mechanism that triggers the antidepressant effect of ketamine on the brain.

In the study published in Nature, researchers from McGill University, Université de Montréal, and Carleton University investigated the effect of ketamine on behaviour and neuronal activity in mice. Using genetic tools to remove proteins from specific brain cells, the team found that when 4E-BPs are absent in the brain, specifically in neurons, ketamine cannot produce its antidepressant effect. 4E-BPs act as a switch to turn on or off the process of protein synthesis - an essential component of memory formation.

"This is yet another prime example of how basic research, in this case the control of protein synthesis, leads to major discoveries in understanding disease, and the hope of curing it," says co-author Nahum Sonenberg, a professor at the Department of Biochemistry at McGill University.

The researchers examined the role of 4E-BPs on ketamine's effect in two major types of neurons: excitatory neurons, which make up most of the neurons in certain parts of the brain, and inhibitory neurons, which control excitatory neurons and have important effects on behaviour.

"We were expecting that 4E-BPs would only be important in excitatory cells, but surprisingly, removing 4E-BPs from inhibitory cells was sufficient to block the effect of ketamine," says co-author Jean-Claude Lacaille, a professor at the Department of Neurosciences at Université de Montréal.

Medicine is not one size fits all

The discovery and approval of ketamine for treatment-resistant patients was considered a major advance in modern psychiatry. Despite its promise, ketamine remains a less-than-perfect therapy because it can be addictive. The researchers hope that their findings will pave the way for better and safer antidepressant therapies for patients with major depressive disorder.

"Too many decisions continue to be made by a trial-and-error approach that can prolong the suffering of patients and affect their quality of life," says co-author Aguilar-Valles, a former research associate at McGill University and now an assistant professor at Carleton University. "Our discovery has the potential to bring us closer to find a safer alternative to ketamine, and ultimately to a personalized medicine approach, where medical treatments are tailored to the individual characteristics of each patient."

The study also involved a clinician-researcher, Dr. Gabriella Gobbi, from the Department of Psychiatry at McGill University, who works with individuals affected with depression and other psychiatric illnesses.

As next steps, the researchers will examine whether males and females have different responses to ketamine. This could have important implications for treatment for people with depressive disorders, among which women are significantly overrepresented.

Credit: 
McGill University